Skip to main content
. 2017 Apr 11;13(6):4208–4214. doi: 10.3892/ol.2017.6024

Table II.

Comparison of receiver operating characteristic AUCs for HTATIP2/TIP30 and AFP among patients with all stages of HCC.

Serum marker HTATIP2/TIP30AUC AFP AUC HTATIP2/TIP30 plus AFP AUC
HCC and control 0.928 0.884 0.963
I–II stage and control 0.825 0.858 0.950

AUC, area under the curve; HTATIP2/TIP30, Tat-interacting protein 30; AFP, α-fetoprotein; HCC, hepatocellular carcinoma.